Omeros (NASDAQ: OMER) announced that the presiding European regulatory authority has approved the company's investigational product OMS721 for compassionate use ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE